4 unknown. 4 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
| Phase 1 | 3 | Unknown 3 |
| Phase 3 | 1 | Unknown 1 |
Follow Spondylosis: new trials by email Literature Review of Spondylosis trials Research Report on Spondylosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion ART352-L - Degenerative Spondylolisthesis | Phase 1 / Phase 2 | Unknown | Ankasa Regenerative Therapeutics, Inc. | 12 | 2020-09-30 | 2020-10-12 |
| Immune Effect of Dexmedetomidine in Patients Undergoing to Spinal Fusion Dexmedetomidine intervention, Placebo - Spine; Arthrosis, Spondylolysis | Phase 2 / Phase 3 | Unknown | Sarah Network of Rehabilitation Hospitals | 46 | 2016-08-01 | 2016-08-23 |
| Pilot Study to Assess Safety/Preliminary Effectiveness of Prefix in Subjects With Degenerative Disc Disease (DDD) Undergoing Spine Fusion Surgery Prefix (AMPLEX) B2A Peptide Enhanced Ceramic Granules, Iliac crest autograft - Degenerative Disc Disease, Spondylolisthesis | Phase 1 / Phase 2 | Unknown | BioSurface Engineering Technologies, Inc | 22 | 2008-11-01 | 2012-03-09 |
| Pilot Study to Assess Safety/Prelimary Effectiveness of Prefix in Subjects With Degenerative Disc Disease (DDD) Undergoing Spine Fusion Surgery Prefix (AMPLEX) B2A Peptide Enhanced Ceramic Granules, Iliac crest autograft - Degenerative Disc Disease, Spondylolisthesis | Phase 1 / Phase 2 | Unknown | BioSurface Engineering Technologies, Inc | 24 | 2008-11-01 | 2012-03-09 |
Spondylolisthesis (4) · Intervertebral Disc Degeneration (3) · Ankylosis (1) · Back Pain (1) · Osteoarthritis (1) · Spondylolysis (1)
Bone Diseases (4) · Musculoskeletal Diseases (4) · Spinal Diseases (4) · Spondylolysis (3) · Arthritis (1) · Joint Diseases (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Rheumatic Diseases (1) · Signs and Symptoms (1)
Adrenergic alpha-2 Receptor Agonists (1) · Dexmedetomidine (1)
BioSurface Engineering Technologies, Inc (2) · Ankasa Regenerative Therapeutics, Inc. (1) · Sarah Network of Rehabilitation Hospitals (1)
United States (2) · Brazil (1) · Canada (1)
Brent Atkinson, PhD (1) · David M Hooper, PhD (1) · Luciano P Miranda (1)